Due to the possible cholesterol issues, moderate anabolic steroid cycles may be best served with SERM’s in order to protect against estrogenic related side effects. SERM’s will not negatively affect cholesterol; in fact, SERM’s like Nolvadex have been shown to promote healthy cholesterol levels due to their ability to act as estrogen in the liver. However, for many a SERM won’t be enough and AI’s will be necessary. If an AI is necessary, the individual should limit his use and only use as much as is actually needed. Some have suggested that a 10mg per day dosing of Nolvadex along with your Arimidex use may actually aid in cholesterol management.
Oral exemestane 25 mg/day for 2–3 years of adjuvant therapy was generally more effective than 5 years of continuous adjuvant tamoxifen in the treatment of postmenopausal women with early-stage estrogen receptor-positive/unknown receptor status breast in a large well-designed [ citation needed ] trial. Preliminary data from the open-label TEAM trial comparing exemestane with tamoxifen indicated in 2009 that exemestane 25 mg/day is also effective in the primary adjuvant treatment of early-stage breast cancer in postmenopausal women.